Published: Sep 05, 2020, 24:45 IST | Updated: Sep 05, 2020, 24:45 IST
According to preliminary results published in The Lancet journal, the COVID-19 vaccine, Sputnik V, approved by Russia last month has been shown to elicit antibody resonse with no serious adverse events in small human trials.